Envoy Medical Inc.
COCH | NASDAQ
$0.72
+$0.01 (+1.34%)
Sep 22, 2026, 11:03 AM ET · Market open
Company Profile
Envoy Medical, Inc. is a healthcare company dedicated to developing innovative medical technologies that address the full spectrum of hearing loss. Its diverse product portfolio includes conventional hearing aids, Esteem middle ear implants, bone conduction devices, and Acclaim cochlear implants. Established in 1995, the company originally operated as St. Croix Medical, Inc. before officially rebranding to Envoy Medical, Inc. in December 2004. Envoy Medical, Inc. is headquartered in White Bear Lake, Minnesota.
Key Executives
| Name | Position |
|---|---|
| Brent Lucas | Chief Executive Officer & Director |
| Robert Potashnick | Interim Chief Financial Officer & Principal Accounting Officer |
| Karin Simonson | Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Sep 02, 2026 | DEFA14A | Filing |
| Aug 31, 2026 | DEF 14A | Filing |
| Aug 27, 2026 | 8-K | Current Report |
| Aug 26, 2026 | 4 | Filing |
| Aug 19, 2026 | PRE 14A | Filing |
| Aug 10, 2026 | 8-K | Current Report |
| Aug 10, 2026 | 10-Q | Quarterly Report |
| Jun 30, 2026 | 8-K | Current Report |
| Jun 25, 2026 | 8-K | Current Report |
| Jun 23, 2026 | 4 | Filing |
Envoy Medical Inc.
| Country | United States |
| IPO Date | Apr 28, 2021 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 43 |
| CEO | Brent T. Lucas |
Contact Details
4875 White Bear Parkway White Bear Lake,
Minnesota 55110 United States
Stock Details
| Ticker Symbol | COCH |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001840877 |
| CUSIP Number | 29415V109 |
| ISIN Number | US29415V1098 |
| SIC Code | 6770 |
Add to Watchlist
Select watchlists to add or remove COCH